Cian Healthcare Limited

CHCL

INE05BN01019

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:56 2024-07-16 am EDT			5-day change	1st Jan Change
20.72 ^INR	-7.13%		-11.83%	+21.38%

2023	Cian Healthcare to Supply 13 Pharmaceutical Products for HLL Lifecare	MT
2023	Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI

Cian Healthcare Limited Announces Resignation of Damodarkumar Sharma as Wholetime Director

July 12, 2022 at 10:34 am EDT

Cian Healthcare Limited has received the resignation letter dated 12th July, 2022 from Mr. Damodarkumar Sharma (DIN: 07984882) Wholetime Director (Executive) of the company which is communicated and received on 12th July, 2022. He will continue the services as Head of Supply Chain & Operations as per the employment agreement. He has resigned from the directorship due to personal commitments.

Latest news about Cian Healthcare Limited

Cian Healthcare to Supply 13 Pharmaceutical Products for HLL Lifecare	Dec. 06	MT
Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2023	Nov. 14	CI
Cian Healthcare to Export Products to Guatemala Via New Deal	23-10-11	MT
Cian Healthcare Limited Enters into Merchant Export Agreement with Tamil Pharma Pvt Ltd	23-10-11	CI
Cian Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-09-05	CI
Cian Healthcare Signs Deal to Manufacture Products for Nigerian Pharmaceutical Firm	23-08-22	MT
Cian Healthcare Limited Enters into an Agreement with CHI Pharmaceuticals Limited	23-08-22	CI
Crisil Lowers Rating on Cian Healthcare's Bank Loans to D; Outlook	23-07-20	MT
Crisil Gives B+ Rating to Cian Healthcare's Bank Loans; Outlook Stable	23-03-02	MT
Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-11-14	CI
Cian Healthcare Limited Announces Resignation of Santosh Pimparkar as Wholetime Director	22-10-08	CI
Cian Healthcare Gets Board's Approval to Move Shares to BSE's Main Board	22-09-26	MT
Cian Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-09-05	CI
Cian Healthcare Limited Appoints Paresh Arun Shah as Additional Director, Date of Appointment Is 25 August, 2022	22-08-26	CI
Cian Healthcare Limited Announces Resignation of Damodarkumar Sharma as Wholetime Director	22-07-12	CI
4,900,000 Equity Shares of Cian Healthcare Limited are subject to a Lock-Up Agreement Ending on 30-MAY-2022.	22-05-29	CI
Cian Healthcare Limited Announces Resignation of Mohammad Raees Sheikh as Non-Executive Independent Director	22-03-31	CI
Cian Healthcare Limited Announces Resignation of Shikha Rai as Independent Non-Executive Director	22-02-25	CI
Cian Healthcare Limited Announce Change in Corporate Office	21-11-23	CI
Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-19	CI
Cian Healthcare Widens Consolidated Net Loss in Fiscal H1	21-11-17	MT
Cian Healthcare Limited Announces Board Changes	21-10-13	CI
Cian Healthcare Limited announced a financing transaction	21-10-11	CI
Cian Healthcare Limited Announces the Resignation of Dhiraj Shantilal Ostwal as Non-Executive Additional Director of the Company	21-10-04	CI
Cian Healthcare Limited Reports Standalone Earnings Results for the Year Ended March 31, 2021	21-09-07	CI

Chart Cian Healthcare Limited

Duration

Period

More charts

Company Profile

Cian Healthcare Limited is an India-based company, which is engaged in the manufacturing and marketing of pharmaceutical products. The Company is engaged in manufacturing of multiple lines-tablets, capsules, soft gels, liquid orals, ointments/ creams and sachets, cosmetics. The Company operates in five sectors, such as Export, Government Supplies, Merchant Export, Own Brand Franchise Business and Third Party/ Contract manufacturing. Its portfolio comprises gynecology, haematinic, cardio- diabetic, orthopedic, pediatric, derma-cosmetic, and antibiotic, CNS, vitamin and nutrient products. The Company also exports its product to various countries, such as Afghanistan, Benin, Bhutan, Bolivia, Cambodia, Sri Lanka, Myanmar and also enhances its production capacity by installing additional machinery for manufacturing a variety of products. It is also engaged in the business of manufacturing cosmetic products. The Company's subsidiary includes Dr. Smith Biotech Private Limited.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CIAN HEALTHCARE LIMITED	+21.38%	6.67M
ELI LILLY AND COMPANY	+61.53%	856B
NOVO NORDISK A/S	+38.95%	631B
JOHNSON & JOHNSON	-3.66%	359B
MERCK & CO., INC.	+15.06%	325B
ABBVIE INC.	+9.18%	297B
ROCHE HOLDING AG	+5.89%	234B
NOVARTIS AG	+16.53%	226B
AMGEN INC.	+15.67%	177B
PFIZER, INC.	+2.47%	165B